Equine Healthcare Market

Equine Healthcare Market (Product Type: Drugs, Vaccines, and Medical Supplemental Feed; Disease Type and Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Equine Healthcare Market Outlook 2028

  • The global market was valued at US$ 698.7 Mn in 2020
  • It is estimated to expand at a CAGR of 4.3% from 2021 to 2028
  • The global equine healthcare industry is expected to cross the value of US$ 972.8 Mn by the end of 2028

Analysts’ Viewpoint on Market Scenario

Equine practitioners are practicing strict biosecurity at all farms, performance venues, racetracks, and the likes during the ongoing COVID-19 pandemic. It has been found that issues of recurring common horse healthcare problems are affecting market growth. Hence, stakeholders in the global market for equine healthcare should increase awareness about regular de-worming schedules and professional veterinary advice to reduce the incidence of recurring common horse healthcare problems. Therapeutics such as corticosteroids are being extensively used as joint injections. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labelled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate use in horses under the age of four.

Comprehensive Equine Vaccine Portfolio Creates Revenue Opportunities for Manufacturers

Equine practitioners are performing a risk-benefit analysis to determine if a horse should receive a particular risk-based vaccine. This is necessary since extra vaccinations can be costly and can cause unnecessary stress to the horse. Manufacturers in the equine healthcare market are increasing the production of vaccines to improve clinical numbers. With the help of risk-benefit analysis, veterinarians are educating horse owners about different types of risk-based vaccines such as equine influenza and strangle vaccines for horses active at events.

Manufacturers in the equine healthcare industry are developing the anthrax vaccine for horses that live in an area where spores are known to thrive in the soil. On the other hand, pregnant mares during specific months of pregnancy are advised to receive certain risk-based vaccines. Companies are developing a diverse portfolio of vaccines such as the equine herpesvirus, botulism, and rotaviral diarrhea.

equine health market infographic

To know the scope of our report Get a Sample of Equine Healthcare Market

AVMA Draws Guidance for Equine Veterinarians amid Ongoing COVID-19 Pandemic

Apart from ensuring healthcare services for horses, the COVID-19 pandemic has drawn attention to the well-being of equine veterinarians. Stakeholders in the equine healthcare market are taking cues from the AVMA (American Veterinary Medical Association) such as following the hierarchy of controls to reduce the spread of novel infection among equine practitioners.

While PPE (personal protective equipment) serves an important protective function, the optimal way to prevent disease transmission is to use a combination of interventions from across the hierarchy of controls. Participants in the equine healthcare business are rescheduling non-urgent veterinary procedures. They are considering telemedicine as an alternative to in-person visits.

Get a glimpse of the in-depth analysis through our Report Brochure

Professional Veterinary Intervention Helps Overcome Recurring Common Horse healthcare Problems

Common horse healthcare problems such as laminitis or thrush can leave a horse more likely to contract it again. Hence, participants in the market are educating horse owners to seek professional veterinary advice and veterinary intervention to improve clinical outcomes.

The high prevalence of allergies, colic, and mud fever, among other common horse healthcare problems, is triggering the demand for healthcare services. Such findings are contributing to the growth of the equine healthcare market. Problems of worms, sweet itch, and back problems are translating into revenue opportunities for market stakeholders.

equine health market segmentation

Expanding operations in the future? To get the perfect launch to ask for a custom report

Wearables Enable Early Indication of healthcare Issues in Horses

Apart from drugs, vaccines, and supplemental feed additives, market stakeholders are boosting R&D in equestrian sports technology such as wearables for horses. As such, there is a need for validated approaches to consistently and regularly track healthcare parameters such as temperature, heart rate, and respiratory rates. Thus, wearable devices hold the promising potential to offer these statistics.

The data gathered by wearable devices have the ability to give an earlier indication of issues, which may require veterinary investigation. Such innovations are translating into incremental opportunities for med-tech companies in the equine healthcare market.

Safety and Welfare of Horses Crucial While Innovating in Therapeutics

In the racing industry, medication use has changed drastically over the years, as manufacturers develop new drugs whilst scientists hone techniques they use to analyze and identify therapeutic medications. healthcare companies are focusing on maintaining a level playing field, protecting the safety of the horse, and protecting the betting public. As such, companies are boosting the production of corticosteroids, NSAIDs, and bisphosphonates, among other drugs.

Racing regulators have historically permitted NSAID use within 24-hrs of race time. However, in recent times, there have been recommendations to increase the timeframe to no earlier than 48-hrs.

Equine Healthcare Industry: Overview

  • According to Transparency Market Research’s latest report on the global equine healthcare market for the historical period 2017–2019 and forecast period 2021–2028, the strong impact of the equine industry on the economy is projected to drive the global market during the forecast period

Strong Impact of Equine Industry on Economy: Key Driver

  • The equine industry involves breeding, keeping, and overall management of horses. It has a strong impact on the overall economy. The industry creates income opportunities for several veterinary physicians, equestrians, and others. Additionally, it involves a supply-demand scenario of equine healthcare products. The strong economic impact of the equine industry is expected to drive the global equine healthcare market.

High Incidence of Equine Infections: Major Driver

  • Horse breeding is a core activity in the equine industry. Hence, the choice of breeding stock and better healthcare management of breeds are crucial to improve breeding operations. The occurrence of equine infections is another major concern for breeders. For instance, South America and the Caribbean have high incidences of Potomac horse fever.
  • The West Nile Virus infection among horses has been controlled; however, the sudden emergence of the virus can cause concerns among horse owners. Moreover, tetanus and equine influenza cases are evident among the global horse community. Hence, a high incidence of equine infections is likely to drive the global equine healthcare market.

Decline in Global Equine Population to Hamper Market

  • The global equine healthcare business has a strong correlation with the global equine population
  • According to research, the horse population in the Americas declined by 5.37% in the past five years, while the horse population declined by 7.47% during the same period
  • Hence, a fall in the global horse population is likely to restrain the global market for equine healthcare during the forecast period

Equine Healthcare Market: Competition Landscape

  • This report profiles major players in the global equine healthcare market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global equine healthcare industry is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global equine healthcare business are
    • Bayer AG (Bayer Animal Healthcare)
    • Boehringer Ingelheim
    • Ceva Santé Animale
    • Eli Lilly and Company (Elanco)
    • Equine Products UK Ltd.
    • Merck & Co. (Merck Animal Healthcare)
    • Sanofi (Merial)
    • Purina Animal Nutrition LLC.
    • Vetoquinol S.A.
    • Zoetis

Equine Healthcare Market: Key Developments

  • Key players in the global equine healthcare market are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few expansion strategies adopted by players operating in the global equine healthcare industry are:
    • Merck & Co. (Merck Animal healthcare) is committed to bringing the latest technologies to research efforts. The company focuses on advancing veterinary medicine through novel solutions in key therapeutic areas. Acquisition of Vallée S.A would make Merck & Co. a renowned player in Brazil, and thereby in Latin America in the near future. Merck & Co. is likely to gain market share in Latin America during the forecast period.
    • Bayer Animal healthcare is a global leader in animal healthcare and helps farmers, veterinarians, and pet owners by offering innovative products. The company develops and commercializes vaccines, drugs, and other products for companion and farm animals. The products reduce the risk of transmission of pathogens from animals to humans. It has expanded its business globally and has a strong presence in North America and Europe. Its primary manufacturing units are in Germany and the U.S.
  • The report on the global equine healthcare market discusses individual strategies, followed by company profiles of manufacturers of equine healthcare products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global market for equine healthcare.

Equine Healthcare Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 698.7 Mn

Market Forecast Value in 2028

US$ 972.8 Mn

Growth Rate (CAGR)

4.3%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross-segment analysis at the regional level. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Products Type
    • Drugs
      • Anti-infectives
      • Anti-inflammatory
      • Parasiticides
      • Others
    • Vaccine
      • Inactivated
      • Live Attenuated
      • Recombinant
      • Others
    • Supplemental Feed additives
      • Proteins & Amino Acids
      • Vitamins
      • Enzymes
      • Minerals
      • Others
  • Distribution Channel
    • Veterinary Hospitals & Clinics
    • Pharmacies & Drug Stores
    • Others
  • Disease Type
    • Equine Influenza
    • Rhinopneumonitis/Equine Herpes Virus (EHV)
    • Equine Encephalomyelitis (sleeping sickness)
    • Equine Infectious Anemia (EIA)
    • West Nile Virus
    • Equine Rabies
    • Potomac Horse Fever
    • Tetanus (Lockjaw)
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Equine Healthcare Market – Segmentation

Product Type
  • Drugs
    • Anti-infectives
    • Anti-inflammatory
    • Parasititidis
    • Others
  • Vaccines
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
  • Supplemental Feed additives
    • Proteins & Amino Acids
    • Vitamins
    • Enzymes
    • Minerals
    • Others
Disease Type
  • Equine Influenza
  • Rhinopneumonitis/Equine Herpes Virus (EHV)
  • Equine Encephalomyelitis (Sleeping Sickness)
  • Equine Infectious Anemia (EIA)
  • West Nile Virus
  • Equine Rabies
  • Potomac Horse Fever
  • Tetanus (Lockjaw)
  • Others
Distribution Channel
  • Veterinary Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of equine healthcare market?

The global market for equine healthcare was worth US$ 698.7 Mn and is projected to reach a value of US$ 972.8 Mn by the end of 2028

What is the anticipated CAGR of the global market for equine healthcare in the forecast period?

The equine healthcare market is anticipated to grow at a CAGR of 4.3% during the forecast period

Which region is expected to project the highest market share in the global equine healthcare business?

North America accounted for a major share of the global market for equine healthcare.

What are the key driving factors for the growth of the equine healthcare industry?

The key factors driving equine healthcare market expansion include increased trend of horseracing and noteworthy growth in spending toward activities pertaining to equine care across the major parts of the globe

Who are the key players in the global equine healthcare business?

Key players in the global equine healthcare industry include Sanofi (Merial), Zoetis, Vetoquinol S.A., Purina Animal Nutrition LLC., and Bayer AG

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Equine Healthcare Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Equine Healthcare Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Bn)

    5. Key Insights

        5.1. Coagulation Disorders & Coagulation Pathways: Overview

        5.2. Epidemiology: Coagulation Disorders

        5.3. Regulatory Framework

        5.4. Reimbursement Scenario

        5.5. Equine Healthcare Market: Pricing Analysis

        5.6. Equine Healthcare Market: Value Chain Analysis

        5.7. Equine Healthcare Market: Porter’s Five Forces Analysis

    6. Global Equine Healthcare Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Equine Healthcare Market Value Forecast, by Product Type, 2017–2028

            6.2.1. Drugs

                6.2.1.1. Anti-infectives

                6.2.1.2. Anti-inflammatory

                6.2.1.3. Parasiticides

                6.2.1.4. Others

            6.2.2. Vaccines

                6.2.2.1. Inactivated

                6.2.2.2. Live Attenuated

                6.2.2.3. Recombinant

                6.2.2.4. Others

            6.2.3. Medical Supplemental Feed

                6.2.3.1. Minerals

                6.2.3.2. Vitamins

                6.2.3.3. Protein

                6.2.3.4. Enzyme

                6.2.3.5. Others

        6.3. Global Equine Healthcare Market Attractiveness Analysis, by Product Type

    7. Global Equine Healthcare Market Analysis and Forecast, by Disease Type

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Equine Healthcare Market Value Forecast, by Disease Type, 2017–2028

            7.2.1. West Nile Virus

            7.2.2. Equine Rabies

            7.2.3. Potomac Horse Fever

            7.2.4. Tetanus

            7.2.5. Equine Influenza

            7.2.6. Equine Herpes Virus

            7.2.7. Equine Encephalomyelitis

            7.2.8. Others (equine infectious anemia)

        7.3. Global Equine Healthcare Market Attractiveness Analysis, by Disease Type

    8. Global Equine Healthcare Market Analysis and Forecast, by Distribution Channel

        8.1. Introduction & Definition

            8.1.1. Key Findings / Developments

        8.2. Global Equine Healthcare Market Value Forecast, by Distribution Channel, 2017–2028

            8.2.1. Veterinary Hospitals & Clinics

            8.2.2. Retail Pharmacies & Drug Stores

            8.2.3. Others

    9. Global Equine Healthcare Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Global Equine Healthcare Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. North America Equine Healthcare Market Attractiveness Analysis, by Region

    10. North America Equine Healthcare Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. North America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

            10.2.1. Drugs

                10.2.1.1. Anti-infectives

                10.2.1.2. Anti-infectives

                10.2.1.3. Anti-inflammatory

                10.2.1.4. Parasiticides

                10.2.1.5. Others

                10.2.1.6. Transfer Lifts

                10.2.1.7. Door Openers

                10.2.1.8. Others

            10.2.2. Vaccines

                10.2.2.1. Inactivated

                10.2.2.2. Live Attenuated

                10.2.2.3. Recombinant

                10.2.2.4. Others

                10.2.2.5. Others

            10.2.3. Medical Supplemental Feed

                10.2.3.1. Minerals

                10.2.3.2. Vitamins

                10.2.3.3. Protein

                10.2.3.4. Enzyme

                10.2.3.5. Others

        10.3. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            10.3.1. West Nile Virus

            10.3.2. Equine Rabies

            10.3.3. Potomac Horse Fever

            10.3.4. Tetanus

            10.3.5. Equine Influenza

            10.3.6. Equine Herpes Virus

            10.3.7. Equine Encephalomyelitis

            10.3.8. Others (equine infectious anemia)

        10.4. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            10.4.1. Veterinary Hospitals & Clinics

            10.4.2. Retail Pharmacies & Drug Stores

            10.4.3. Others

        10.5. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2017–2027

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Equine Healthcare Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Disease Type

            10.6.3. By Distribution Channel

            10.6.4. By Country

    11. Europe Equine Healthcare Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Europe Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

            11.2.1. Drugs

                11.2.1.1. Anti-infectives

                11.2.1.2. Anti-infectives

                11.2.1.3. Anti-inflammatory

                11.2.1.4. Parasiticides

                11.2.1.5. Others

                11.2.1.6. Transfer Lifts

                11.2.1.7. Door Openers

                11.2.1.8. Others

            11.2.2. Vaccines

                11.2.2.1. Inactivated

                11.2.2.2. Live Attenuated

                11.2.2.3. Recombinant

                11.2.2.4. Others

                11.2.2.5. Others

            11.2.3. Medical Supplemental Feed

                11.2.3.1. Minerals

                11.2.3.2. Vitamins

                11.2.3.3. Protein

                11.2.3.4. Enzyme

                11.2.3.5. Others

        11.3. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            11.3.1. West Nile Virus

            11.3.2. Equine Rabies

            11.3.3. Potomac Horse Fever

            11.3.4. Tetanus

            11.3.5. Equine Influenza

            11.3.6. Equine Herpes Virus

            11.3.7. Equine Encephalomyelitis

            11.3.8. Others (Equine Infectious Anemia)

        11.4. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            11.4.1. Veterinary Hospitals & Clinics

            11.4.2. Retail Pharmacies & Drug Stores

            11.4.3. Others

        11.5. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Europe Equine Healthcare Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Disease Type

            11.6.3. By Distribution Channel

            11.6.4. By Country/Sub-region

    12. Asia Pacific Equine Healthcare Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Asia Pacific Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

            12.2.1. Drugs

                12.2.1.1. Anti-infectives

                12.2.1.2. Anti-infectives

                12.2.1.3. Anti-inflammatory

                12.2.1.4. Parasiticides

                12.2.1.5. Others

                12.2.1.6. Transfer Lifts

                12.2.1.7. Door Openers

                12.2.1.8. Others

            12.2.2. Vaccines

                12.2.2.1. Inactivated

                12.2.2.2. Live Attenuated

                12.2.2.3. Recombinant

                12.2.2.4. Others

                12.2.2.5. Others

            12.2.3. Medical Supplemental Feed

                12.2.3.1. Minerals

                12.2.3.2. Vitamins

                12.2.3.3. Protein

                12.2.3.4. Enzyme

                12.2.3.5. Others

        12.3. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            12.3.1. West Nile Virus

            12.3.2. Equine Rabies

            12.3.3. Potomac Horse Fever

            12.3.4. Tetanus

            12.3.5. Equine Influenza

            12.3.6. Equine Herpes Virus

            12.3.7. Equine Encephalomyelitis

            12.3.8. Others (equine infectious anemia)

        12.4. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            12.4.1. Veterinary Hospitals & Clinics

            12.4.2. Retail Pharmacies & Drug Stores

            12.4.3. Others

        12.5. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Asia Pacific Equine Healthcare Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Disease Type

            12.6.3. By Distribution Channel

            12.6.4. By Country/Sub-region

    13. Latin America Equine Healthcare Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Latin America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

            13.2.1. Drugs

                13.2.1.1. Anti-infectives

                13.2.1.2. Anti-infectives

                13.2.1.3. Anti-inflammatory

                13.2.1.4. Parasiticides

                13.2.1.5. Others

                13.2.1.6. Transfer Lifts

                13.2.1.7. Door Openers

                13.2.1.8. Others

            13.2.2. Vaccines

                13.2.2.1. Inactivated

                13.2.2.2. Live Attenuated

                13.2.2.3. Recombinant

                13.2.2.4. Others

                13.2.2.5. Others

            13.2.3. Medical Supplemental Feed

                13.2.3.1. Minerals

                13.2.3.2. Vitamins

                13.2.3.3. Protein

                13.2.3.4. Enzyme

                13.2.3.5. Others

        13.3. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            13.3.1. West Nile Virus

            13.3.2. Equine Rabies

            13.3.3. Potomac Horse Fever

            13.3.4. Tetanus

            13.3.5. Equine Influenza

            13.3.6. Equine Herpes Virus

            13.3.7. Equine Encephalomyelitis

            13.3.8. Others (equine infectious anemia)

        13.4. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            13.4.1. Veterinary Hospitals & Clinics

            13.4.2. Retail Pharmacies & Drug Stores

            13.4.3. Others

        13.5. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America Latin America

        13.6. Latin America Equine Healthcare Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Disease Type

            13.6.3. By Distribution Channel

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Middle East & Africa Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017–2028

            14.2.1. Drugs

                14.2.1.1. Anti-infectives

                14.2.1.2. Anti-infectives

                14.2.1.3. Anti-inflammatory

                14.2.1.4. Parasiticides

                14.2.1.5. Others

                14.2.1.6. Transfer Lifts

                14.2.1.7. Door Openers

                14.2.1.8. Others

            14.2.2. Vaccines

                14.2.2.1. Inactivated

                14.2.2.2. Live Attenuated

                14.2.2.3. Recombinant

                14.2.2.4. Others

                14.2.2.5. Others

            14.2.3. Medical Supplemental Feed

                14.2.3.1. Minerals

                14.2.3.2. Vitamins

                14.2.3.3. Protein

                14.2.3.4. Enzyme

                14.2.3.5. Others

        14.3. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            14.3.1. West Nile Virus

            14.3.2. Equine Rabies

            14.3.3. Potomac Horse Fever

            14.3.4. Tetanus

            14.3.5. Equine Influenza

            14.3.6. Equine Herpes Virus

            14.3.7. Equine Encephalomyelitis

            14.3.8. Others (equine infectious anemia)

        14.4. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            14.4.1. Veterinary Hospitals & Clinics

            14.4.2. Retail Pharmacies & Drug Stores

            14.4.3. Others

        14.5. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Middle East & Africa Equine Healthcare Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Disease Type

            14.6.3. By Distribution Channel

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share / Position Analysis, by Company, 2020

        15.3. Competitive Business Strategies

        15.4. Company Profiles

            15.4.1. Bayer AG (Bayer Animal Healthcare)

                15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.1.2. Financial Analysis

                15.4.1.3. Growth Strategies

                15.4.1.4. SWOT Analysis

            15.4.2. Boehringer Ingelheim

                15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.2.2. Financial Analysis

                15.4.2.3. Growth Strategies

                15.4.2.4. SWOT Analysis

            15.4.3. Ceva Santé Animale

                15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.3.2. Financial Analysis

                15.4.3.3. Growth Strategies

                15.4.3.4. SWOT Analysis

            15.4.4. Eli Lilly and Company (Elanco)

                15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.4.2. Financial Analysis

                15.4.4.3. Growth Strategies

                15.4.4.4. SWOT Analysis

            15.4.5. Equine Products U.K. Ltd.

                15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.5.2. Financial Analysis

                15.4.5.3. Growth Strategies

                15.4.5.4. SWOT Analysis

            15.4.6. Merck & Co. (Merck Animal Healthcare)

                15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.6.2. Financial Analysis

                15.4.6.3. Growth Strategies

                15.4.6.4. SWOT Analysis

            15.4.7. Sanofi (Merial)

                15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.7.2. Financial Analysis

                15.4.7.3. Growth Strategies

                15.4.7.4. SWOT Analysis

            15.4.8. Purina Animal Nutrition LLC

                15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.8.2. Financial Analysis

                15.4.8.3. Growth Strategies

                15.4.8.4. SWOT Analysis

            15.4.9. Vetoquinol S.A.

                15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.9.2. Financial Analysis

                15.4.9.3. Growth Strategies

                15.4.9.4. SWOT Analysis

            15.4.10. Zoetis

                15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.10.2. Financial Analysis

                15.4.10.3. Growth Strategies

                15.4.10.4. SWOT Analysis

    List of Table

    Table 01: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

    Table 02: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

    Table 03: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

    Table 04: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Region, 2021–2028

    Table 05: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

    Table 06: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

    Table 07: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

    Table 08: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Country, 2021–2028

    Table 09: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

    Table 10: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

    Table 11: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

    Table 12: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

    Table 13: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

    Table 14: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

    Table 15: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

    Table 16: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

    Table 17: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

    Table 18: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

    Table 19: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

    Table 20: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

    Table 21: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021–2028

    Table 22: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021–2028

    Table 23: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021–2028

    Table 24: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021–2028

    List of Figure

    Figure 01: Equine Healthcare Market Snapshot

    Figure 02: Global Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2028

    Figure 03: Market Value Share, by Product, 2020

    Figure 04: Market Value Share, by Disease Type, 2020

    Figure 05: Market Value Share, by Distribution Channel, 2020

    Figure 06: Market Value Share, by Region, 2020

    Figure 07: Global Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

    Figure 08: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2028

    Figure 09: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017–2028

    Figure 10: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Supplemental Feed, 2017–2028

    Figure 11: Global Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

    Figure 12: Global Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

    Figure 13: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by West Nile Virus, 2017–2028

    Figure 14: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EQUINE RABIES, 2017–2028

    Figure 15: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Potomac Horse Fever, 2017–2028

    Figure 16: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetanus, 2017–2028

    Figure 17: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Influenza, 2017–2028

    Figure 18: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Herpes Virus, 2017–2028

    Figure 19: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Encephalomyelitis, 2017–2028

    Figure 20: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Equine Infectious Anemia), 2017–2028

    Figure 21: Global Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

    Figure 22: Global Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

    Figure 23: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals & Clinics, 2017–2028

    Figure 24: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies & Drug Stores, 2017–2028

    Figure 25: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2028

    Figure 26: Global Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

    Figure 27: Global Equine Healthcare Market Value Share Analysis, by Region, 2020 and 2028

    Figure 28: Global Equine Healthcare Market Attractiveness Analysis, by Region, 2021–2028

    Figure 29: North America Equine Healthcare Market Size (US$ Mn) Forecast, 2021–2028

    Figure 30: North America Equine Healthcare Market Attractiveness Analysis, by Country, 2021–2028

    Figure 31: North America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

    Figure 32: North America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

    Figure 33: North America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

    Figure 34: North America Equine Healthcare Market Value Share Analysis, by Country, 2020 and 2028

    Figure 35: North America Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

    Figure 36: North America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

    Figure 37: North America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

    Figure 38: Europe Equine Healthcare Market Size (US$ Mn) Forecast, 2021–2028

    Figure 39: Europe Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 40: Europe Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

    Figure 41: Europe Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

    Figure 42: Europe Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

    Figure 43: Europe Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 44: Europe Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

    Figure 45: Europe Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

    Figure 46: Europe Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

    Figure 47: Asia Pacific Equine Healthcare Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017– 2028

    Figure 48: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 49: Asia Pacific Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

    Figure 50: Asia Pacific Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

    Figure 51: Asia Pacific Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

    Figure 52: Asia Pacific Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 53: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

    Figure 54: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

    Figure 55: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

    Figure 56: Latin America Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

    Figure 57: Latin America Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 58: Latin America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

    Figure 59: Latin America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

    Figure 60: Latin America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

    Figure 61: Latin America Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 62: Latin America Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

    Figure 63: Latin America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

    Figure 64: Latin America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

    Figure 65: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, 2017–2028

    Figure 66: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 67: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028

    Figure 68: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028

    Figure 69: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028

    Figure 70: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 71: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Product, 2021–2028

    Figure 72: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021–2028

    Figure 73: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021–2028

    Figure 74: Global Equine Healthcare Market Share Analysis, by Company, 2020

Copyright © Transparency Market Research, Inc. All Rights reserved